These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9201104)

  • 1. Cardiac involvement in progressive muscular dystrophy of the Duchenne type.
    Ishikawa K
    Jpn Heart J; 1997 Mar; 38(2):163-80. PubMed ID: 9201104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy.
    Yanagisawa A; Yokota N; Miyagawa M; Kawamura J; Ishihara T; Aoyagi T; Ishikawa K
    Am Heart J; 1990 Nov; 120(5):1154-8. PubMed ID: 2146865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heart in human dystrophinopathies.
    Finsterer J; Stöllberger C
    Cardiology; 2003; 99(1):1-19. PubMed ID: 12589117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of cardiac changes in Duchenne muscular dystrophy.
    Heymsfield SB; McNish T; Perkins JV; Felner JM
    Am Heart J; 1978 Mar; 95(3):283-94. PubMed ID: 622971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients.
    Perloff JK
    J Am Coll Cardiol; 1984 May; 3(5):1263-8. PubMed ID: 6707378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study.
    Sasaki K; Sakata K; Kachi E; Hirata S; Ishihara T; Ishikawa K
    Am Heart J; 1998 Jun; 135(6 Pt 1):937-44. PubMed ID: 9630096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac manifestation of progressive muscular dystrophy of the Duchenne type].
    Angermann C; Spes C; Pongratz D
    Z Kardiol; 1986 Sep; 75(9):542-51. PubMed ID: 3788261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral valve prolapse syndrome in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Leung RK; Tierney RC; Gilmartin R; Pitner S
    Pediatrics; 1979 Jan; 63(1):116-23. PubMed ID: 440788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heart in Duchenne muscular dystrophy: a non-invasive longitudinal study.
    Bäckman E; Nylander E
    Eur Heart J; 1992 Sep; 13(9):1239-44. PubMed ID: 1396835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophic degeneration of papillary muscle and ventricular myocardium. A basis for mitral valve prolapse in Duchenne's muscular dystrophy.
    Sanyal SK; Johnson WW; Dische MR; Pitner SE; Beard C
    Circulation; 1980 Aug; 62(2):430-8. PubMed ID: 7397983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.
    Frankel KA; Rosser RJ
    Hum Pathol; 1976 Jul; 7(4):375-86. PubMed ID: 939536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Fragmented QRS Complexes and Cardiac Status in Duchenne Muscular Dystrophy: Multimodal Validation Using Echocardiography, Magnetic Resonance Imaging, and Holter Monitoring.
    Cho MJ; Lee JW; Lee J; Shin YB; Lee HD
    Pediatr Cardiol; 2017 Jun; 38(5):1042-1048. PubMed ID: 28456833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic evaluation of cardiac abnormalities in Duchenne's dystrophy and myotonic muscular dystrophy.
    Reeves WC; Griggs R; Nanda NC; Thomson K; Gramiak R
    Arch Neurol; 1980 May; 37(5):273-7. PubMed ID: 7387444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late potentials in progressive muscular dystrophy of the Duchenne type.
    Yotsukura M; Ishizuka T; Shimada T; Ishikawa K
    Am Heart J; 1991 Apr; 121(4 Pt 1):1137-42. PubMed ID: 2008837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyopathy of Duchenne muscular dystrophy.
    D'Orsogna L; O'Shea JP; Miller G
    Pediatr Cardiol; 1988; 9(4):205-13. PubMed ID: 3237504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy].
    Kimura C; Kawai H; Adachi K; Nishiuchi T; Saito S
    Rinsho Shinkeigaku; 1989 Mar; 29(3):290-5. PubMed ID: 2526701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement.
    Stevenson WG; Perloff JK; Weiss JN; Anderson TL
    J Am Coll Cardiol; 1990 Feb; 15(2):292-9. PubMed ID: 2299071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrocardiographic and vectorcardiography studies and correlation with myocardial lesions in Duchenne type progressive muscular dystrophy].
    Uematsu H; Yokota M; Yamauchi K; Hayashi H; Sotobata I; Sobue I
    Nihon Naika Gakkai Zasshi; 1982 Sep; 71(9):1245-56. PubMed ID: 7153626
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy.
    Mori K; Manabe T; Nii M; Hayabuchi Y; Kuroda Y; Tatara K
    Pediatr Cardiol; 2002; 23(2):160-6. PubMed ID: 11889527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak negative myocardial velocity gradient and wall-thickening velocity during early diastole are noninvasive parameters of left ventricular diastolic function in patients with Duchenne's progressive muscular dystrophy.
    Mori K; Edagawa T; Inoue M; Nii M; Nakagawa R; Takehara Y; Kuroda Y; Tatara K
    J Am Soc Echocardiogr; 2004 Apr; 17(4):322-9. PubMed ID: 15044864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.